Provides the first real world data (outside a clinical trial) on the dosing of THC:CBD in amyotrophic lateral sclerosis (ALS).
Terpenes’ contribution to therapeutic effect of cannabinoids “may be significant.”
Synthetic THC combiner Obsessive Compulsive Disorder: A marked reduction in symptoms, according to new research out of the New York State Psychiatric Institute.
Researchers have discovered that cannabis is frequently used to alleviate diarrhea, abdominal pain, and loss of appetite caused by inflammatory bowel disease.
Several clinical trials are planned or underway to assess the effectiveness of THC and CBD in treating these conditions, such a Crohn’s and colitis.
Large clinical trial – King’s College London – seeks to affirm CBD as a treatment for psychosis..
“CBD has emerged as a promising candidate as it displays anti-anxiety and anti-psychotic like properties in animals and humans.”
Drug company earning multi-millions on MS med containing only 2 ingredients – THC and CBD ready to launch epilepsy drug this fall & now racing to develop CBD drugs for schizophrenia, #autism & other hard-to treat diseases.
Link btwn cannabis and glaucoma known for 25 yrs.
CBD has beneficial effects in patients with schizophrenia and may represent a new class of treatment for the disorder.
THC produces opposite effects in the brain compared with CBD, according to Australian researchers who reviewed 31 scientific papers on the topic.
These changes are especially pronounced in brain regions that are rich in cannabinoid receptors, according to the study.